+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 10Months
All Genders
ID07342621

Study to Assess the Effects of an Extensively Hydrolyzed Infant Formula With Synbiotics and a Human Milk Oligosaccharide on Infants Under 10 Months With Cows Milk Protein Allergy

Led by Outcomes'10 · Updated on 2026-01-15

41

Participants Needed

13

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Cows milk protein allergy CMPA is a common food allergy in infants, affecting between 2% and 5% of this population. It can cause symptoms in the skin, digestive system, respiratory system, or more widespread reactions, impacting infant growth and family quality of life. Researchers are studying an extensively hydrolyzed whey-based infant formula containing a synbiotic mixture, human milk oligosaccharide 2-fucosyllactose 2-FL, and reduced lactose to evaluate its clinical effects on infants with suspected or confirmed CMPA in routine care settings. This prospective, open-label, single-arm study will include about 41 infants under 10 months old across multiple primary care centers and one hospital in Valencia, Spain. Participants will receive the study formula as their first hypoallergenic formula and be followed for four weeks. A subgroup of infants will provide stool samples to explore changes in gut microbiota caused by the formula. During the study, parents or guardians will complete questionnaires on allergy symptoms, gastrointestinal function, and product acceptability, while clinicians will record clinical data and infant growth measurements. The main outcome is the change in physician-reported allergy symptoms from the start to week 4. Additional assessments include parent-reported symptoms, stool characteristics, parental quality of life, infant growth, and safety monitoring. The study aims to better understand the formulas effects in real-world practice.

CONDITIONS

Brief Title

SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)

Research Team

M

Mónica Rodríguez, Medical Manager Peads

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here